Zena is a registered nurse, who holds a PhD, a FFNMRCSI, an MSc in Wound Healing & Tissue Repair, an MSc in Leadership in Education, a PGDip in Wound Healing & Tissue Repair and a Diploma in Management. Zena is the Chair in Nursing at the RCSI, University of Medicine and Health Sciences, is Head of the School of Nursing & Midwifery and is Director of the Skin Wounds, and Trauma (SWaT) Research Centre at RCSI. Zena’s area of research interest is Wound Healing & Tissue Repair and she has published over 210 articles, guidelines, consensus documents and book chapters in this field. Zena is a trustee of the European Pressure Ulcer Advisory Panel, where she is a member of the executive Board, Chair of the Scientific Committee, a member of the International Guideline Governance Group and the Advocacy group. Zena is also a Past President of the European Wound Management Association, is an Adjunct Professor, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia, a Professor at the Department of Public Health, Faculty of Medicine and Health Sciences, Ghent University, an Honorary Professor, Lida Institute, Shanghai, China, an Honorary Visiting Professor at the University of Wales, a visiting lecturer at the Faculty of Health Sciences, Hogskolen i Buskerud, Drammen, Norway and an Adjunct Professor, Department of Nursing, Fakeeh College for Medical Sciences, Jeddah, KSA.

Marco Meloni is MD,PhD, Researcher Fellow at University of Tor Vergata in Roma. The field of research is the prevention and management of diabetic foot. He's a member of International Diabetic Foot Care Group and Italian Study Group of Diabetic Foot.

Professor Michael Edmonds is a Consultant Physician at King’s College Hospital in London with a special responsibility for care of the diabetic foot. He developed a multi-disciplinary diabetic foot clinic in 1981, one of the first in the world. This clinic brought about a 50% reduction in major amputations in people with diabetes at King’s College Hospital. He is a past Chairman of the Diabetic Foot Study Group of the European Association of the Study of Diabetes.

Vladica is a medical doctor by training and Doctoral Candidate in Health Technology Assessment under Professor Uwe Siebert's mentorship focusing on research related to decision analysis. His doctoral thesis is related to benefit-harm and cost-effectiveness assessment of high-sensitive troponin assay diagnostic strategies for myocardial infarction. Vladica has demonstrated a history of working in academia, health economics consulting industry, pharmaceutical and MedTech industry. His research in academia is mostly focused on health economics and outcomes research in diagnostic and precision medicine. At Global Senior Health Economist position in HARTMANN GROUP, he has conducted cost-effectiveness analyses for wound care products mostly focusing on EU, US, China and Australia. Recently Vladica starts to utilize more machine learning methods in his daily work. He is taking extended training in the leading universities concerning machine learning in clinical research. He is author of more than 30 scientific papers.